Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
BACKGROUND & AIMS: The association between sarcopenia and prognosis in patients with cirrhosis remains to be determined. In this study, we aimed to quantify the association between sarcopenia and the risk of mortality in patients with cirrhosis, stratified by sex, underlying liver disease etiology, and severity of hepatic dysfunction. METHODS: PubMed, Web of Science, EMBASE, and major scientific conference sessions were searched without language restriction through 13 January 2021 with an additional manual search of bibliographies of relevant articles. Cohort studies of ≥100 patients with cirrhosis and ≥12 months of follow-up that evaluated the association between sarcopenia, muscle mass and the risk of mortality were included. RESULTS: Twenty-two studies involving 6,965 patients with cirrhosis were included. The pooled prevalence of sarcopenia in patients with cirrhosis was 37.5% overall (95% CI 32.4%-42.8%), and was higher in male patients, those with alcohol-associated liver disease, those with Child-Pugh grade C cirrhosis, and when sarcopenia was defined by L3-SMI (third lumbar-skeletal muscle index). Sarcopenia was associated with an increased risk of mortality in patients with cirrhosis (adjusted hazard ratio [aHR] 2.30, 95% CI 2.01-2.63), with similar findings in a sensitivity analysis of patients with cirrhosis without hepatocellular carcinoma (aHR 2.35, 95% CI 1.95-2.83) and in subgroups stratified by sex, liver disease etiology, and severity of hepatic dysfunction. The association between quantitative muscle mass index and mortality further supports the association between sarcopenia and poor prognosis (aHR 0.95, 95% CI 0.93-0.98). There was no significant heterogeneity in any of our analyses. CONCLUSIONS: Sarcopenia was highly and independently associated with higher risk of mortality in patients with cirrhosis. LAY SUMMARY: The prevalence of sarcopenia and its association with death in patients with cirrhosis remain unclear. This meta-analysis indicated that sarcopenia affected about one-third of patients with cirrhosis and up to 50% of patients with alcohol-related liver disease or Child-Pugh class C cirrhosis. Sarcopenia was independently associated with an ∼2-fold higher risk of mortality in patients with cirrhosis. The mortality rate increased with greater severity or longer durations of sarcopenia. Increasing awareness about the importance of sarcopenia in patients with cirrhosis among stakeholders must be prioritized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2014) · Medical Entomology and Zoology · Cited by 17,633
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2_v1 · Cited by 8,090
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J., Bossuyt, P., Boutron, I., Hoffmann, T., mulrow, C., Shamseer, L., Tetzlaff, J., Akl, E., Brennan, S. E., et al. (2020) · doi:10.31222/osf.io/v7gm2 · Cited by 5,177
Cruz-Jentoft, A. J., & Sayer, A. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31138-9 · Cited by 3,905
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Metaprop: a Stata command to perform meta-analysis of binomial data
Nyaga, V. N., Arbyn, M., & Aerts, M. (2014) · Archives of Public Health · doi:10.1186/2049-3258-72-39 · Cited by 2,139
The model for end-stage liver disease (MELD)
Kamath, P. S., & Kim, R. W. (2007) · Hepatology · doi:10.1002/hep.21563 · Cited by 1,674
Iorio, A., Spencer, F. A., Falavigna, M., Alba, C., Lang, E., Burnand, B., McGinn, T., Hayden, J., Williams, K., Shea, B., et al. (2015) · BMJ · doi:10.1136/bmj.h870 · Cited by 880
Lai, J. C., Tandon, P., Bernal, W., Tapper, E. B., Ekong, U., Dasarathy, S., & Carey, E. J. (2021) · Hepatology · doi:10.1002/hep.32049 · Cited by 742
Peters, J. L., Sutton, A. J., Jones, D. R., Abrams, K. R., & Rushton, L. (2007) · Statistics in Medicine · doi:10.1002/sim.2889 · Cited by 716
Sarcopenia from mechanism to diagnosis and treatment in liver disease
Dasarathy, S., & Merli, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.040 · Cited by 608
Tandon, P., Ney, M., Irwin, I., Ma, M. M., Gramlich, L., Bain, V. G., Esfandiari, N., Baracos, V., Montano-Loza, A. J., & Myers, R. P. (2012) · Liver Transplantation · doi:10.1002/lt.23495 · Cited by 574
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
D'Amico, G., Pasta, L., Morabito, A., D'Amico, M., Caltagirone, M., Malizia, G., Tinè, F., Giannuoli, G., Traina, M., Vizzini, G., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12721 · Cited by 547
A multicenter study to define sarcopenia in patients with end-stage liver disease
Carey, E. J., Lai, J. C., Wang, C. W., Dasarathy, S., Lobach, I., Montano‐Loza, A. J., Dunn, M. A., & for the Fitness, L. E. (2017) · Liver Transplantation · doi:10.1002/lt.24750 · Cited by 498
Sarcopenia and frailty in decompensated cirrhosis
Tandon, P., Montano-Loza, A. J., Lai, J. C., Dasarathy, S., & Merli, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.025 · Cited by 408
Sarcopenia impairs prognosis of patients with liver cirrhosis
Hanai, T., Shiraki, M., Nishimura, K., Ohnishi, S., Imai, K., Suetsugu, A., Takai, K., Shimizu, M., & Moriwaki, H. (2015) · Nutrition · doi:10.1016/j.nut.2014.07.005 · Cited by 390
Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography
Durand, F., Buyse, S., Francoz, C., Laouénan, C., Bruno, O., Belghiti, J., Moreau, R., Vilgrain, V., & Valla, D. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.026 · Cited by 384
Kim, G., Kang, S. H., Kim, M. Y., & Baik, S. K. (2017) · PLOS ONE · doi:10.1371/journal.pone.0186990 · Cited by 369
van Vugt, J. L. A., Levolger, S., de Bruin, R. W. F., van Rosmalen, J., Metselaar, H. J., & IJzermans, J. N. M. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13732 · Cited by 361
Self-citationMontano-Loza, A. J., Duarte-Rojo, A., Meza-Junco, J., Baracos, V. E., Sawyer, M. B., Pang, J. X. Q., Beaumont, C., Esfandiari, N., & Myers, R. P. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.31 · Cited by 355
Montano-Loza, A. J., Meza-Junco, J., Baracos, V. E., Prado, C. M. M., Ma, M., Meeberg, G., Beaumont, C., Tandon, P., Esfandiari, N., Sawyer, M. B., et al. (2014) · Liver Transplantation · doi:10.1002/lt.23863 · Cited by 297
Montano-Loza, A. J. (2014) · Liver Transplantation · doi:10.1002/lt.23978 · Cited by 237
Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis
Bunchorntavakul, C., & Reddy, K. R. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15571 · Cited by 217
van Vugt, J. L. A., Alferink, L. J. M., Buettner, S., Gaspersz, M. P., Bot, D., Darwish Murad, S., Feshtali, S., van Ooijen, P. M. A., Polak, W. G., Porte, R. J., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.030 · Cited by 208
Self-citationPraktiknjo, M., Book, M., Luetkens, J., Pohlmann, A., Meyer, C., Thomas, D., Jansen, C., Feist, A., Chang, J., Grimm, J., et al. (2018) · Hepatology · doi:10.1002/hep.29602 · Cited by 162
Self-citationLow subcutaneous adiposity associates with higher mortality in female patients with cirrhosis
Ebadi, M., Tandon, P., Moctezuma‐Velázquez, C., Ghosh, S., Baracos, V. E., Mazurak, V. C., & Montaño‐Loza, A. J. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.04.015 · Cited by 158
Wang, C. W., Feng, S., Covinsky, K. E., Hayssen, H., Zhou, L.-Q., Yeh, B. M., & Lai, J. C. (2016) · Transplantation · doi:10.1097/tp.0000000000001232 · Cited by 150
Kang, S. H., Jeong, W. K., Baik, S. K., Cha, S. H., & Kim, M. Y. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12333 · Cited by 150
Important predictor of mortality in patients with end-stage liver disease
Kim, H. J., & Lee, H. W. (2013) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2013.19.2.105 · Cited by 145
Ebadi, M., Wang, C. W., Lai, J. C., Dasarathy, S., Kappus, M. R., Dunn, M. A., Carey, E. J., Montano‐Loza, A. J., & From the Fitness, L. E. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12349 · Cited by 142
Praktiknjo, M., Clees, C., Pigliacelli, A., Fischer, S., Jansen, C., Lehmann, J., Pohlmann, A., Lattanzi, B., Krabbe, V., Strassburg, C. P., et al. (2019) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000025 · Cited by 131
Self-citationGu, D. H., Kim, M. Y., Seo, Y. S., Kim, S. G., Lee, H. A., Kim, T. H., Jung, Y. K., Kandemir, A., Kim, J. H., An, H., et al. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0077 · Cited by 128
Sarcopenia in Alcoholic Liver Disease: Clinical and Molecular Advances
Dasarathy, J., McCullough, A. J., & Dasarathy, S. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13425 · Cited by 120
Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis
Meyer, F., Bannert, K., Wiese, M. L., Esau, S., Sautter, L. F., Ehlers, L., Aghdassi, A. A., Metges, C. C., Garbe, L., Jaster, R., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155357 · Cited by 108
Ruiz‐Margáin, A., Xie, J. J., Román-Calleja, B. M., Pauly, M., White, M. G., Chapa-Ibargüengoitia, M., Campos-Murguía, A., González-Regueiro, J. A., Macías‐Rodríguez, R. U., & Duarte‐Rojo, A. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.08.066 · Cited by 101
Continued muscle loss increases mortality in cirrhosis: Impact of aetiology of liver disease
Welch, N., Dasarathy, J., Runkana, A., Penumatsa, R., Bellar, A., Reen, J., Rotroff, D., McCullough, A. J., & Dasarathy, S. (2020) · Liver International · doi:10.1111/liv.14358 · Cited by 81
Prioritization for liver transplantation
Cholongitas, Ε., Germani, G., & Burroughs, A. K. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.169 · Cited by 71
Lattanzi, B., Nardelli, S., Pigliacelli, A., Cola, S. D., Farcomeni, A., D’Ambrosio, D., Gioia, S., Corradini, S. G., Lucidi, C., Mennini, G., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.09.004 · Cited by 61
Piotrowski, D., Sączewska-Piotrowska, A., Jaroszewicz, J., & Boroń‐Kaczmarska, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17051727 · Cited by 61
Mauro, E., Crespo, G., Martinez-Garmendia, A. M., Gutierrez‐Acevedo, M. N., Diaz, J. M., Saidman, J. M., Bermúdez, C., Patron, J. O., Garcia‐Olveira, L., Zalazar, F., et al. (2020) · Transplantation · doi:10.1097/tp.0000000000003222 · Cited by 61
Self-citationMRI‐defined sarcopenia predicts mortality in patients with chronic liver disease
Beer, L., Bastati, N., Ba‐Ssalamah, A., Pötter-Lang, S., Lampichler, K., Bican, Y., Lauber, D. A., Hodge, J. C., Binter, T., Pomej, K., et al. (2020) · Liver International · doi:10.1111/liv.14648 · Cited by 52
Sinclair, M. J., Hoermann, R., Peterson, A. R., Testro, A., Angus, P., Hey, P., Chapman, B., & Gow, P. J. (2019) · Liver International · doi:10.1111/liv.14071 · Cited by 51
Engelmann, C., Schob, S., Nonnenmacher, I., Werlich, L., Aehling, N., Ullrich, S., Kaiser, T., Krohn, S., Herber, A., Sucher, R., et al. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15026 · Cited by 45
Self-citationHou, L., Deng, Y., Fan, X., Zhao, T., Cui, B., Lin, L., Hou, J., Mao, L., Zhao, W., Jiang, K., et al. (2020) · Journal of Parenteral and Enteral Nutrition · doi:10.1002/jpen.1841 · Cited by 44
Self-citationJeong, J. Y., Lim, S., Sohn, J. H., Lee, J. G., Jun, D. W., & Kim, Y. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e299 · Cited by 42
Self-citationClinical impact of sarcopenia assessment in patients with liver cirrhosis
Marasco, G., Dajti, E., Ravaioli, F., Brocchi, S., Rossini, B., Alemanni, L. V., Peta, G., Bartalena, L., Golfieri, R., Festi, D., et al. (2020) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2021.1848542 · Cited by 40
Clinical utility of bioimpedance analysis in liver cirrhosis
Nishikawa, H., Enomoto, H., Iwata, Y., Nishimura, T., Iijima, H., & Nishiguchi, S. (2017) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.455 · Cited by 34
Wang, N. C., Zhang, P., Tapper, E. B., Saini, S. D., Wang, S. C., & Su, G. L. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000662 · Cited by 31
Self-citationHamaguchi, Y., Kaido, T., Okumura, S., Kobayashi, A., Shirai, H., Yao, S., Yagi, S., Kamo, N., & Üemoto, S. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.08.012 · Cited by 27
Self-citationChang, K. C., Chen, J.-D., Wu, W., Huang, K., & Han, D. (2019) · Medicine · doi:10.1097/md.0000000000014373 · Cited by 26
Hiraoka, A., Kitahata, S., Izumoto, H., Ueki, H., Aibiki, T., Okudaira, T., Miyamoto, Y., Yamago, H., Iwasaki, R., Tomida, H., et al. (2017) · Hepatology Research · doi:10.1111/hepr.12984 · Cited by 19
Models for acute on chronic liver failure development and mortality in a veterans affairs cohort
Xiao, K. Y., Hubbard, R. A., Kaplan, D. E., Taddei, T. H., Goldberg, D. S., & Mahmud, N. (2020) · Hepatology International · doi:10.1007/s12072-020-10060-y · Cited by 19
Belarmino, G., Torrinhas, R. S., Magalhães, N. V., Heymsfield, S. B., & Waitzberg, D. L. (2020) · Nutrition · doi:10.1016/j.nut.2020.111083 · Cited by 8
Research works printed but not linked: 1
- Xiao, 2020, Risk factors of cirrhosis combined with sarcopenia and their impact on clinical outcomes, Zhonghua Gan Zang Bing Za Zhi, 28, 53
Cited by
Epidemiology of sarcopenia: Prevalence, risk factors, and consequences
Yuan, S., & Larsson, S. C. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155533 · Cited by 1,114
Impact of GLP-1 Receptor Agonist Therapy in Patients High Risk for Sarcopenia
Memel, Z., Gold, S. L., Pearlman, M., Muratore, A., & Martindale, R. (2025) · Current Nutrition Reports · doi:10.1007/s13668-025-00649-w · Cited by 63
Osteosarcopenia in NAFLD/MAFLD: an underappreciated clinical problem in chronic liver disease
Musio, A., Perazza, F., Leoni, L., Stefanini, B., Dajti, E., Menozzi, R., Petroni, M. L., Colecchia, A., & Ravaioli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087517 · Cited by 26
“In a meta-analysis of 22 studies involving 6965 patients [82], the pooled prevalence of sarcopenia in patients with LC was 37.”
BackgroundMethod
Metadata
- Authors
- Tantai, X., Liu, Y., Yeo, Y. H., Praktiknjo, M., Mauro, E., Hamaguchi, Y., Engelmann, C., Zhang, P., Jeong, J. Y., van Vugt, J. L. A., Xiao, H., Deng, H., Gao, X., Ye, Q., Zhang, J., Yang, L., Cai, Y., Liu, Y., Liu, N., Li, Z., Han, T., Kaido, T., Sohn, J. H., Strassburg, C., Berg, T., Trebicka, J., Hsu, Y.-C., IJzermans, J. N. M., Wang, J., Su, G. L., Ji, F., & Nguyen, M. H.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2022-03
- Volume
- 76
- Issue
- 3
- Pages
- 588-599
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3214325528
- Cited by
- 426
- References
- 57
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.